A significant shortage of estrogen patches is affecting women across the United States who are seeking hormone replacement therapy (HRT) to manage symptoms of perimenopause and menopause. The demand for these patches has surged, resulting in challenges for women trying to find effective treatment options.
According to a study by Epic Research, the number of women using hormone replacement therapy has increased by 72% since 2021. This rise is attributed to heightened awareness of menopause and changes implemented by the U.S. Food and Drug Administration (FDA), which removed the boxed warning from certain hormone therapies, encouraging more prescriptions. Despite this progress, supply chain issues and a lack of insurance coverage for brand-name alternatives have compounded the difficulties faced by patients.
Women like Martie Jo Pennisi, a professional organizer from Glendale, California, have experienced firsthand the consequences of this shortage. After struggling with severe menopause symptoms since October 2020, Pennisi found relief with an estradiol patch and a progesterone pill. “I had everything in the book,” she recalled, describing symptoms such as depression, anxiety, and debilitating hot flashes. However, when she attempted to refill her prescription last month, her pharmacy informed her that the estradiol patch was unavailable.
“I contacted multiple pharmacies across the county, but none had the estradiol patch in stock,” Pennisi said. Frustrated, she faced the reality of a treatment interruption, highlighting the urgent need for solutions.
Dr. Jessica Shepherd, a menopause expert, noted that the shortage is indicative of both progress in women’s healthcare and ongoing supply chain challenges. “The good news is that more women are asking for estradiol in the form of a patch,” she explained. “The bad news is that we see a supply chain issue, which is affecting pharmacies nationwide.”
As women increasingly seek help for symptoms previously considered taboo, the healthcare system is struggling to keep pace with demand. The shift in societal attitudes surrounding menopause has encouraged women to discuss their experiences openly, leading to more consultations and prescriptions.
During this challenging period, Dr. Shepherd recommends that patients explore alternative forms of estradiol, such as creams, gels, pills, or pellets. “There’s no difference in how it works,” she assured. “Some people may notice differences in how their body responds, but you won’t know until you try it.”
While Pennisi ultimately found a weekly estradiol patch as a substitute for her usual twice-weekly version, she expressed her gratitude mixed with frustration over the situation. “If the world experienced men losing all their testosterone at once, there would be a whole different story,” she remarked, emphasizing the need for greater recognition of women’s health issues.
The shortage has prompted some women to switch from generic to brand-name hormone treatments. Unfortunately, these brand-name options are often not covered by insurance and can cost hundreds of dollars per month, further complicating access to necessary care.
As the demand for hormone replacement therapy continues to grow, the healthcare industry must address the underlying supply chain issues to ensure that women receive the treatment they need. With ongoing advocacy and awareness, there is hope that the situation will improve, allowing women to manage their menopause symptoms more effectively.